09/05/2014 - 10:21am

Univision on Thursday announced the official sponsors for its singing reality competition, “Va Por Ti” (This One’s For You) , a co-production of Televisa and Univision. 

09/03/2014 - 10:56am

To help encourage early detection of diabetes in communities around the United States, Sam’s Club Pharmacy will host free diabetes screenings to both members and non-members on Sept. 13.

08/26/2014 - 11:51am

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States.

08/25/2014 - 12:20pm

Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system.

08/19/2014 - 12:04pm

The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.

08/11/2014 - 11:15am

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

08/06/2014 - 1:02pm

BD Medical, a segment of BD, on Wednesday announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front- and back-end shields that provides greater convenience and safety before and after injecting. 

08/01/2014 - 12:07pm

The Food and Drug Administration announced approval for Boehringer Ingelheim's Jardiance tablets.

07/30/2014 - 10:32am

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.